​

Daré Bioscience (DARE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DARE Stock Forecast

Daré Bioscience (DARE) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 468.72% increase from the last price of $2.11.

- $3 $6 $9 $12 $15 High: $12 Avg: $12 Low: $12 Last Closed Price: $2.11

DARE Stock Rating

Daré Bioscience stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

DARE Price Target Upside V Benchmarks

TypeNameUpside
StockDaré Bioscience468.72%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.11$2.11$2.11
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2612---3
Mar, 2612---3
Feb, 2613---4
Jan, 2613---4
Dec, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Douglas TsaoH.C. Wainwright$12.00$3.50242.86%468.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024H.C. WainwrightBuyBuyhold
Aug 13, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.52$-4.39$-4.15$-0.48$-1.20---
Avg Forecast$-7.03$-3.80$-4.46$-0.35$-1.52$-1.34$0.41$7.63
High Forecast$-5.00$-3.80$-3.81$-0.24$-1.14$-0.20$0.61$7.63
Low Forecast$-9.80$-3.80$-5.23$-0.46$-1.90$-2.47$0.21$7.63
Surprise %6.97%15.53%-6.95%37.14%-21.05%---

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$10.00M$2.81M$9.78K$1.03B---
Avg Forecast$1.67M$10.00M$3.38M$1.08M$3.27M$42.10M$70.18M$272.61M
High Forecast$2.17M$10.00M$3.55M$2.12M$3.27M$42.10M$70.18M$272.61M
Low Forecast$1.30M$10.00M$3.20M$36.52K$3.27M$42.10M$70.18M$272.61M
Surprise %---16.83%-99.09%31436.52%---

Net Income Forecast

$-15B $-11B $-7B $-3B $1B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-38.70M$-30.95M$-30.16M$-4.05M$-13.40B---
Avg Forecast$-51.16M$-27.65M$-30.16M$-2.55M$-11.06M$-9.71M$2.98M$55.47M
High Forecast$-36.35M$-27.65M$-27.72M$-1.77M$-8.26M$-1.42M$4.44M$55.47M
Low Forecast$-71.29M$-27.65M$-38.02M$-3.33M$-13.85M$-18.01M$1.53M$55.47M
Surprise %-24.36%11.94%-59.19%121067.57%---

DARE Forecast FAQ

Is Daré Bioscience stock a buy?

Daré Bioscience stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Daré Bioscience is a favorable investment for most analysts.

What is Daré Bioscience's price target?

Daré Bioscience's price target, set by 6 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 468.72% change from the previous closing price of $2.11.

How does Daré Bioscience stock forecast compare to its benchmarks?

Daré Bioscience's stock forecast shows a 468.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Daré Bioscience over the past three months?

  • April 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Daré Bioscience’s EPS forecast?

Daré Bioscience's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.34, marking a 11.67% increase from the reported $-1.2 in 2025. Estimates for the following years are $0.41 in 2027, and $7.63 in 2028.

What is Daré Bioscience’s revenue forecast?

Daré Bioscience's average annual revenue forecast for its fiscal year ending in December 2026 is $42.1M, reflecting a -95.91% decrease from the reported $1.03B in 2025. The forecast for 2027 is $70.18M, and $272.61M for 2028.

What is Daré Bioscience’s net income forecast?

Daré Bioscience's net income forecast for the fiscal year ending in December 2026 stands at $-9.713M, representing a -99.93% decrease from the reported $-13.399B in 2025. Projections indicate $2.98M in 2027, and $55.47M in 2028.